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PEMBANGUNAN ASAI GELUNG-DIMEDIASI AMPLIFIKASI 
ISOTHERMAL BAGI PENGESANAN YANG PANTAS DAN SENSITIF 
TERHADAP Vibrio cholerae TOKSIGENIK
ASBTRAK
Taun dikenali sebagai masalah kesihatan awam yang ketara di seluruh dunia yang 
disebabkan oleh Vibrio cholerae toksigenik. Pada masa ini, rutin diagnosis bagi taun 
melibatkan  bakteria  kultur  dan  ujian  biokimia  tetapi  kaedah  konvensional  ini 
memakan masa, kurang cekap, sukar dan kakitangan yang mahir diperlukan untuk 
melaksanakan tugas-tugas tersebut. Sehingga kini, tiada kit diagnostik molekul yang 
pantas  di  mana  ianya  boleh  didapati  secara  komersial  dan  boleh  digunakan  di 
makmal  dan  kerja  lapangan.  Oleh  itu,  kajian  ini  telah  memberi  tumpuan kepada 
membangunkan asai multipleks LAMP untuk diagnosis taun yang mudah, cepat dan 
sangat sensitif.  Primers pada asalnya direka untuk mengesan gen toksigenik, ctxA 
yang hanya wujud dalam strain toksigenik V. cholerae dan satu gen kawalan dalaman 
(SSP2). Spesifikasi primers telah disahkan oleh analisis carian BLAST dan diuji pada 
strain  bakteria  lain  bagi  memastikan  bahawa  gen  sasaran  adalah  sangat  spesifik. 
Kawalan dalaman telah digunakan untuk pengesahan pada kebolehpercayaan asai 
LAMP bagi  mengelakkan  keputusan  negatif  palsu.  Asai  multipleks  LAMP stabil 
suhu terdiri  daripada format kering dan basah. Bagi format kering, komponennya 
adalah 0.6 mM campuran dNTPs, 1.6 pmol/ ul setiap FIP dan BIP bagi kedua-dua 
sasaran dan kawalan dalaman, 0.8 pmol/ ul LB dan LF untuk kedua-dua sasaran dan 
kawalan  dalaman,  0.2  pmol/  ul  setiap  F3  dan  B3  untuk  kedua-dua  sasaran  dan 
kawalan dalaman,  4.27 U /  ul  daripada Bst  2.0 WarmStart  Polymerase DNA dan 
xvi
kombinasi penstabil enzim dipilih (8% trehalose + 0.25 mg/ ml BSA + 6% FICOLL) 
dengan  0.05% Orange  G pewarna  gel.  Format  basah  terdiri  daripada  1X LAMP 
penguatan  penampan,  6  mM  MgSO4,  dan  0.4  M  betaine  dan  disimpan  sebagai 
penampan akueus. 13.3 pg / ul daripada SSP2 plasmid DNA telah disepadukan dalam 
setiap larian yang berfungsi sebagai kawalan dalaman. Multipleks LAMP stabil suhu 
telah diuji bagi ujian kestabilan dipercepatkan pada 25 dan 37 ℃ selama 1 bulan. 
Campuran multipleks LAMP stabil suhu disimpan pada 25 dan 37 ℃ adalah stabil 
sehingga  1  bulan.  Walau  bagaimanapun,  selepas  pengiraan  dipercepatkan  ujian 
kestabilan  haba,  ia  mampu  bertahan  pada  suhu  bilik  selama  3.14  bulan  dalam 
hubungan dengan suhu simpanan 37 ℃.  Keputusan multipleks LAMP stabil suhu 
yang diperolehi menunjukkan 100% spesifik terhadap 73 strain V. cholerae  sahaja 
dan  bukan  kepada  5  spesies  Vibrio  dan  37  strain  bukan  Vibrio.  Sensitiviti  asai 
multipleks LAMP stabil suhu yang dikesan di peringkat genomik adalah 100 fg/ ul 
dan  102  CFU/  ml  pada  peringkat  bakteria.  Pembangunan  asai  multipleks  LAMP 
stabil suhu adalah pantas, sangat sensitif dan spesifik untuk mengesan V. cholerae 
yang  toksigenik.  Asai  ini  mempunyai  potensi  untuk  mengawal  wabak  penyakit 
berjangkit dan secara tidak langsung membantu dalam mengurangkan morbiditi dan 
kematian yang disebabkan oleh taun.
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DEVELOPMENT OF A LOOP-MEDIATED ISOTHERMAL 
AMPLIFICATION ASSAY FOR SENSITIVE AND RAPID DETECTION OF 
TOXIGENIC Vibrio cholerae
ABSTRACT
Cholera is known as significant public health problem worldwide which is caused by 
toxigenic Vibrio cholerae. Currently, the routine cholera diagnosis involves bacterial 
culture  and  biochemical  tests  but  conventional  methods  are  time  consuming, 
inefficient,  laborious and skilled personnel is  required to perform the tasks.  Until 
now, no rapid molecular diagnostic kits commercially accessible that can be used in 
laboratory and field settings. Consequently, this study was focused on developing a 
multiplex  LAMP assay  for  detection  of  cholera  that  is  simple,  fast  and  highly 
sensitive. The designed primers were constructed for the detection of toxigenic gene, 
ctxA that presents only in toxigenic strains of V. cholerae and one internal control 
(SSP2). BLAST search analyses were used to confirm the primers specificity and the 
same primers were also tested on other non-Vibrio bacterial strains to ensure that the 
target gene is highly specific. The reliability of LAMP assay to rule out false negative 
result  was  validated  with  the  inclusion  of  an  internal  control.  The  optimised 
thermostabilised multiplex LAMP assay consists  of  dry  and wet  format.  For  dry 
format, the components were 0.6 mM dNTPs mixture, 1.6 pmol/ µl of each FIP and 
BIP for both target and internal control, 0.8 pmol/ µl of LB and LF for both target 
and internal control, 0.2 pmol/ µl of each F3 and B3 for both target and internal 
control,  4.27 U/ µl of Bst  2.0 WarmStart DNA polymerase and enzyme stabiliser 
combinations selected (8% trehalose + 0.25 mg/ ml BSA + 6% FICOLL) with 0.05% 
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Orange G loading dye. The wet format composed of 1X LAMP amplification buffer, 
6 mM MgSO4, and 0.4 M betaine and kept as aqueous buffer. A 13.3 pg/ µl of SSP2 
plasmid DNA was integrated in each run which functions as internal control. The 
thermostabilised multiplex LAMP was tested for accelerated stability test at 25 and 
37  ℃  for  1  month.  Results  showed  that  the  thermostabilised  multiplex  LAMP 
mixture  stored  at  25  and  37  ℃  was  stable  until  1  month.  After  calculation  of 
accelerated heat  stability test,  it  can last  at  room temperature for 3.14 months in 
correlation with 37 ℃ storage. The multiplex LAMP assay results obtained showed 
100% specific with 73 V. cholerae strains only and not for 5 Vibrio species and 37 
non-Vibrio  strains.  The  analytical  sensitivity  of  the  multiplex  LAMP  assay  at 
genomic level was 100 fg/ µl whereas at bacterial level, the limit of detection was 
found to be 102 CFU/ ml, respectively. The developed thermostabilised multiplex 
LAMP assay  is  fast  and  distinctly  sensitive  and  specific  for  the  recognition  of 
toxigenic V. cholerae.  This assay has potential  to be implemented during cholera 
outbreak  and  consequentially  helpful  in  reducing  the  morbidity  and  mortality  of 
cholera cases. 
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CHAPTER 1
1. INTRODUCTION
1.1. Vibrio cholerae
Vibrio cholerae is classified under genus Vibrio and known to be Gram-negative, 
facultative anaerobic organism, about 1.4 -  2.6 µm long curved-rod bacteria,  and 
motile  caused by the presence of  a  single flagellum. It  is  oxidase positive (from 
Oxidase test) and reduces nitrates to nitrites (Nair, 2002). It is known as the causative 
agent for profuse, severe watery diarrhoea disease to human being called cholera. 
Even so, not all V. cholerae strains are toxigenic to human due to wide diversity of 
strains  with  varies  of  virulence  gene  contents  (Heidelberg  et  al.,  2000).  Unlike 
different  Vibrio  species,  V.  cholerae  are  also  natural  free-living  inhabitants  at 
riverine, estuarine and coastal water areas. 
V. cholerae  can be distinguished from other Vibrio  species through application of 
biochemical  tests,  the components  of  lipopolysaccharide (LPS) and the ability  to 
produce cholera toxin (Finkelstein, 1996). The chemical structure of V. cholerae LPS 
consists of  three distinct regions known as lipid A, the core oligosaccharide and the 
O antigen (Manning et al., 1994). Particularly, the O antigen carries the heat-stable 
O-serotype  specificity  and  also  antigen  determinants  which  is  widely  used  to 
distinguished between V. cholerae strains in serology.
These  bacteria  grow  rapidly  in  adequate  media  within  30  minutes  period  with 
vigorous aeration with an optimum temperature of 37 ºC. Although they are able to 
live at pH range of 5.0 - 9.6, they can live optimally at pH 7.6 but die quickly at pH 
less than 6.0 (Desmarchelier, 1997). Even so, they are able to grow at pH 8.0 - 9.5 
 1
which  impede  most  of  Gram-negative  bacteria.  The  tolerance  of  V.  cholerae  to 
alkaline conditions has been utilised in media preparation for isolation process in the 
laboratory  (Finkelstein,  1996).  Naturally,  this  gives  the  bacteria  to  well  adapt  in 
intestinal environment by adhering to small bowel and release their toxigenic cholera 
toxin protein although mostly are killed in the stomach acid barrier.
1.1.1. Taxonomy of V. cholerae
The hierarchy categorisation of V. cholerae is listed in Table 1.1.
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Table 1.1: Taxonomy classification of V. cholerae bacterium
Classification order Details
Kingdom Bacteria
Phylum Proteobacteria
Class Gamma Proteobacteria
Order Vibrionales
Family Vibrionaceae
Genus Vibrio
Species V. cholerae
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1.1.2. Nomenclature and strain categorisation of V. cholerae
V. cholerae is a clearly described organism based on the biochemical tests performed 
and  also  from  DNA  homologous  research  (Baumann  et  al.,  1984)  but  not 
homogenous in terms of toxigenic potential. In specific, to distinguish within Vibrio 
species  are  based  on  the  cholera  toxin  production,  serogroup  and  possibility  of 
causing infestation outbreak. Previously, the public health declared the V. cholerae 
O1  strains  were  correlated  with  epidemic  and  pandemic  cholera  while  other 
serogroups  were  either  non-toxigenic  or  only  occasionally  causing  disease 
(Chowdhury  et  al.,  2015;  Rashed  et  al.,  2012).  However,  in  early  90s,  a  new 
serogroup O139 had caused  epidemic  outbreak  in  eastern  India  and Bangladesh. 
Thus, in present, major cholera outbreaks have been associated with these two major 
serogroups, O1 and O139 (Raychoudhuri et al., 2009) while other serogroup which 
caused seasonal and sporadic diarrhoea cases are mentioned as non-O1/ non-O139 
serogroups.  The identified V. cholerae  strains are found to be approximately 200 
serogroups which based on specific agglutination test against O antigen (Faruque et 
al., 2003).
In  history  of  cholera  disease,  V.  cholerae  O1  strain  has  been  correlated  with 
infestation and widespread of cholera due to production of cholera toxin. However, 
there are certain isolates of V. cholerae O1 serogroup did not produce cholera toxin 
particularly the environmental strains (Kaper et al., 1981; Levine et al., 1982). This 
serogroup is subcategorised into serotypes mainly Ogawa and Inaba while Hikojima 
is  seldom  isolated.  The  Classical  and  El  Tor  biotypes  are  categorised  under  V. 
cholerae O1 serogroup and each of serotypes combinations can be formed from these 
two  biotypes.  The  El  Tor  biotype  is  different  from  Classical  biotype  by  being 
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haemolytic, positive in the Voges-Proskauer test which detects specific fermentation 
pathway while negative in Polymyxin B sensitivity test (Bopp et al., 1999; Feng et 
al., 2008). 
Recently, before appearance of new serogroup O139, each of the V. cholerae isolates 
were referred as non-O1 V. cholerae  due to the absence of agglutination with O1 
antisera but with the presence of O139 serogroup, one might categorise the O2 until 
O138 as non-epidemic V. cholerae. The non-O1/ non-O139 strains were determined 
based on the LPS somatic antigen in which the cholera toxin is not produceable but 
they are able to produce enterotoxins similar to cholera toxin (Begum et al., 2006). 
Even  so,  they  were  not  associated  with  epidemic  and  pandemic  cholera  cases 
(Morris,  1990).  These  strains  are  commonly  responsible  for  sporadic,  localised 
outbreaks (Dutta et al., 2013), and mainly due to ingestion of shellfish and also from 
variety  of  extra  intestinal  disorders  inclusive  of  lesions,  ear,  sputum,  urine  and 
cerebrospinal fluid (Hughes et al., 1987; Morris, 2003). 
The first case of O139 serogroup was isolated from Eastern India and Bangladesh 
where at first it was mentioned as non-O1 V. cholerae due to absence of agglutination 
with  O1  antisera.  Nonetheless,  later  investigation  has  disclosed  this  bacteria 
belonged to a new serogroup called O139 and synonym of “Bengal” for the origin of 
this  strain  (Bhattacharya  et  al.,  1993;  Faruque  et  al.,  2003;  Kaper  et  al.,  1995). 
Researchers  emphasised  that  V.  cholerae  O139  Bengal  are  acquired  from  the 
pandemic of O1, El Tor biotype due to lateral gene transfer between O1 and non-O1 
strains (Nair, 2002). It produces similar cholera toxin of O1 strains but does not have 
similar characteristic of somatic O1 antigen. 
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1.1.3. Virulence related genes
Cholera toxin genetic elements (CTX) and pathogenicity islands (VPI) are the main 
virulence genes of V. cholerae located in two regions of the chromosome (Faruque et 
al.,  1998;  Karaolis  et  al.,  1998;  Rajanna  et  al.,  2003).  The  4.5  kb  core  region 
virulence cassette of toxigenic factors grouped in the CTX genetic elements contains 
cholera enterotoxin, the main protein secretion that causes severe watery diarrhoea, 
is encoded by ctxAB genes (comprising A and B subunits) which is absent in non-
cholera Vibrios (Nair, 2002). Other virulence factors includes zonula occludens toxin 
(zot), core-encoded pilin (cep), accessory cholera enterotoxin (ace), and a product of 
unknown function (orfU) (Fasano et al., 1991; Trucksis et al., 1993). Whereas VPI 
comprises virulence genes sets, virulence gene regulators, transposase gene, specific 
attachment sites flanking each end of the island, and a integrase with homology to a 
phage integrase gene (Faruque et al., 1998). The virulence proteins available on VPI 
integrate  with  toxin-coregulated  pili  (TCP)  and  the  accessory  colonisation  factor 
(ACF) during colonisation in human intestine. 
The TCP acts as the receptor of CTX phage that is important for colonisation of V. 
cholerae in small intestine. The expression of cholera toxin and TCP are co-regulated 
by the regulator proteins for virulence. The site-specific recombination process of 
excision and insertion of 41.2 kb VPI into the host chromosome involves termini 
integrase gene and the attachment sites, whereas the transposase gene linking its left 
and right ends to mediate the circularisation of the excised VPI (Almagro-Moreno et 
al., 2010; Rajanna et al., 2003). Thus, the VPI can construct a non-replicative circular 
intermediate product that needs transferring mechanism like conjugative transposons, 
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generalised  transducing  phages  or  uptake  by  transformation  process  (Almagro-
Moreno et al., 2010). 
1.2. Summary of cholera disease
Cholera is an acute diarrhoea, clinical-epidemiologic illness caused by toxigenic V. 
cholerae  strains.  The  severity  of  the  infection  is  described  as  profuse  and  high 
voluminous passage of stools of rice water characteristic,  accompanied by severe 
dehydration, acidosis, vomiting, hypovolemic shock and death if not treated rapidly 
(Ghose, 2011). The vehicle of transmission mainly through poor sanitation practice, 
famine incident, lack of treated and clean water supplies and also a proper sewage 
system which is commonly occurred in the Third World countries. Since 1961, the V. 
cholerae El Tor biotype caused the seventh pandemic of cholera until today. The new 
serogroup O139 has  been reported  to  cause  major  outbreaks  in  certain  countries 
which has increase the awareness among researchers that this might be the causative 
agent for eighth pandemic of cholera. 
1.2.1. Epidemiology of cholera
Originally,  cholera  belonged  to  old  world  and  turn  out  to  be  one  of  the  main 
infectious illness in previous time with increment of incidence in recent epidemics in 
Haiti  (2010 -  2012),  Vietnam (2008)  and Zimbabwe (2009).  In  2013,  WHO has 
recorded 129 064 cases of cholera from 47 countries in which 43% were described in 
Africa and 47% described in America with an approximate burden of  1.4 to 4.3 
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million cases, and every year from 28 000 to 142 000 of mortality cases globally 
(World Health Organization, 2015b). 
V. cholerae  has been indicated as etiologic agent for cholera in 1883 where fifth 
pandemic was occurred at the moment (Koch, 1884). Since 1817 until present day, 
the world has been stroked by seven pandemics and the sixth pandemic between 
1899 and 1923 is responsible by classical biotype (Pollitzer, 1954). Nevertheless, this 
classical biotype is no longer exists and has been replaced (Samadi et al., 1983) with 
the seventh causative agent for seventh pandemic, the El Tor biotype. According to 
previous  studies,  the  seventh  pandemic  strain  was  first  isolated  in  Sulawesi, 
Indonesia and later outspread all over Southeast Asia including Malaysia to Asian 
mainland (Kaper et al., 1995). It also causes large-scale epidemics in the Middle East 
areas and neighbouring countries (Cohen et al., 1971; Goodgame and Greenough, 
1975; Kaper et al., 1995).
However,  the  emergence  of  new  serogroup  O139  Bengal  in  India  (1992),  has 
alarmed  the  researchers  of  the  possibility  for  eighth  pandemic  cholera  to  occur 
(Bhattacharya et al., 1993). Though this strain has persistently been isolated in Asia 
but it has the possibility to continue and outspread to other mainlands. Presently, the 
cholera outbreaks are responsible by V. cholerae O1 and O139 serogroups.
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1.2.2. Outbreaks in Malaysia
Although Malaysia is categorised as one of the non-endemic countries in cholera 
cases  worldwide  (Ali  et  al.,  2015),  but  there  are  still  some  cases  occasionally 
occurred all over the country. In Malaysia, cholera outbreaks mainly occur due to El 
Tor  biotype  of  O1  serogroup  periodically  and  for  O139  serogroup  occurs 
sporadically while non-O1/ non-O139 serogroup so far has not been involved in any 
major outbreak (Ang et al., 2010; Chen et al., 2004; Teh et al., 2011).  In 2006, there 
were  237  cholera  cases  with  2  deaths  reported  by  Department  of  Public  Health 
(DPH), Ministry of Health Malaysia (http://www.dph.gov.my/survelans/Statistik). 
In  three  years  time,  another  cholera  outbreak  has  struck  Terengganu,  Peninsular 
Malaysia in November 2009 with 187 cases and one death that were caused by two 
V. cholerae El Tor biotypes that were unsusceptible to particular antibiotics (Teh et 
al., 2012). In August 2012, cholera outbreak has been reported in Bintulu, Sarawak 
(East  Malaysia)  with  27  V.  cholerae  samples  confirmed  for  toxigenic  ctx  gene 
(Bilung et al., 2014). The latest cholera cases reported occurred in Kota Belud, Sabah 
(East Malaysia) by the local media with three cases due to lack supply of treated 
water (Rintod, 2013). This reveals that within recent years, a serious increment of 
cholera cases have occurred and need to be carefully observed. 
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1.2.3. Pathophysiology of cholera
V. cholerae  is widely known to cause infection in human though it  also exists in 
environmental. The vehicle of transmission mainly from fecal-oral route particularly 
from consumption of contaminated food and water with V. cholerae. Even though V. 
cholerae is killed in the acid barrier of stomach but some of it might pass through 
and colonise the small intestine epithelium via their fimbria and TCP to perforate the 
mucus lying over the mucosa (Sack et al., 2004). 
When the pathogens settled in epithelium, the toxigenic V. cholerae started to secrete 
84 kDa cholera toxin protein which is expressed by ctxAB gene (subunit A and B) 
(Harris  et  al.,  2012).  The  secretion  of  cholera  toxin  goes  into  the  lumen  of  the 
extracellular  surroundings  which  disrupts  the  ion  transportation  and  leads  to  the 
opening of normally gated channels in the intestinal epithelial cells. The B subunits 
(56 kDa) started to bind the toxin to the GM1 ganglioside receptors, natural receptor 
of  cholera  toxin  in  human  while  the  A subunit  activates  adenylate  cyclase  after 
transported into the cell results in increment of cyclic AMP (cAMP) together with 
excretion of chloride inside crypt cells and inhibits the absorption of sodium chloride 
in the villus cells (Banerjee, 2010; Sack et al., 2004). This results in an enormous 
reflux of fluid and electrolyte loss in the form of watery diarrhoea as one of cholera 
symptoms. 
Generally cholera patients produced a high concentration of toxigenic V. cholerae up 
to 108 per gram which possibly contaminate the water supplies and food and also 
seen as environmental reservoir for transmission of cholera mainly in countries that 
lack of proper human sewage system and sanitation practice (Sack et al., 2004). 
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1.2.4. Clinical presentations of cholera
Generally,  only  minority  of  people  developed  cholera  gravis,  which  is  the  most 
severe manifestation after infected with toxigenic V. cholerae. In report by WHO, 
about 75% of people infected with cholera were asymptomatic and 80% of them 
developed mild  diarrhoea.  However  in  20% cases,  they developed a  very severe 
cholera manifestation that can lead to death within hours compared to a healthy adult 
(World Health Organization, 2014). The symptom of loss in electrolyte fluid leads to 
depletion of blood volume resulted in hypotension and shock while potassium and 
bicarbonate ions loss through diarrhoea resulted in metabolic acidosis and deficiency 
in potassium ions in the body, and subsequently, death in untreated cases (Harris et 
al., 2012; Sack et al., 2004). 
After 24 to 48 hours of incubation period, usually cholera patients begin to show 
symptoms such as painless abdominal cleanse of immense stools that resembles rice 
water accompanied by intense fishy odour, where the rate of purging is quick and can 
reach up to 500 - 1000 ml/ h and results in acute dehydration (Fazil and Singh, 2011; 
Harris et al., 2012). The characteristic of vomit characteristic usually clear, watery, 
alkaline  fluid  and  thus,  an  immediate  admission  of  rehydration  fluids  must  be 
provided to reduce the risks of death within few hours of onset of disease.
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1.2.5. Cholera interventions
The  typical  and  effective  intervention  for  cholera  patients  is  by  admitting  with 
rehydration  fluids  to  recover  the  body  fluid  loss  and  also  to  maintain  normal 
hydration  status.  Usually  the  administration  of  rehydration  fluids  are  carried  out 
based on the severity of the dehydration status as guided by WHO which based on 
clinical signs and symptoms showed from patients. 
Patients  with  a  very  severe  dehydration  status  should  be  given  lactated  Ringer 
solution or isotonic sodium chloride solution in every 2 - 5 hours intravenously based 
on age and body weight (World Health Organization, 1993). Administration of oral 
rehydration  salt  (ORS)  can  also  be  given  to  patients  as  it  contains  potassium, 
bicarbonate,  glucose  and  chloride  via  intravenous  or  nasogastric  tube  to  helps 
restoring the patient condition with moderate dehydration status. 
Antibiotics have been implemented as an adjunct to hydration intervention, however, 
they alone are insufficient to hinder the mortality of cholera (Centers for Disease 
Control and Prevention, 2015; Das et al., 2013). Generally, moderate and severely ill 
patients older than two years old are administered with antibiotics concurrence with 
rehydration therapy to lessen the fluid lost and to reduce the secretion of V. cholerae 
(Seas et al., 1996). Usually about 50% of illness can be decreased with an effective 
antibiotic therapy accompanied by shorter elimination of V. cholerae in stool in one 
or two days in comparison to exceed five days without any antibiotics intervention 
(Nelson et al., 2011). 
Doxycycline  antibiotic  has  been  endorsed  by  WHO  as  the  first  choice  of 
antimicrobial agent by giving as a single dose of 300 mg for an adult and 6 mg/ kg in 
children between 1 and 14 years of age to cholera infected patients. Azithromycin 
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and erythromycin  have  been  used  as  first  line  regimen in  children  and  pregnant 
women and they were found to be effective and appropriate (Centers for Disease 
Control and Prevention, 2015; Nelson et al., 2011). 
Apart  from  these  therapies,  zinc  supplementation  admission  occurrence  with 
antibiotic and rehydration therapy has shown in reduction of period and acuteness of 
diarrhoea and chances of following infections for 2 - 3 months in children (Roy et 
al., 2008). 
1.2.6. Prevention controls and public sanitation
Even though the cholera intervention seems to be simple and uncomplicated by just 
administering rehydration fluids to replace lost body fluids and electrolytes, however, 
in countries which experience poverty and lack of clean water supplies, this problem 
might arises particularly when lacking of medical assistance and supplies. In such 
countries, the poorly treated cholera cases can result in increasing of death rates from 
20%  to  50%  during  the  epidemic  season.  Thus,  a  proper  management  in 
environmental hygienic practices and sanitation and also vaccination can be carried 
out to hinder and control the outspread of cholera as well as reducing the mortality 
rates. 
The spreading of cholera disease is due to inaccessible to treated, good quality of 
water supplies in a sufficient amount. Chlorination of water reservoir is effective in 
improving the quality of water supply by diminishing the existence of pathogens in 
the water. An efficient sanitation of personal hygiene and domestic hygiene such as 
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food handling and sewage management system can minimise the transmission of 
cholera disease. 
1.2.7. Cholera diagnosis
Cholera diagnosis mainly implements the gold standard method by identification of 
causative  agent  by culture  method,  biochemical  and serological  test  (Dick et  al., 
2012). The clinical specimens collected from diarrhoea patients are either stool or 
rectal  swab.  Isolation  of  V.  cholerae  is  performed  using  alkaline  peptone  water 
(APW) due to its capability of reproducing effectively in alkaline pH for a duration 
of 6 to 8 hours (Kaper et al., 1995). Then, the isolates are cultured on thiosulphate-
citrate-bile salts-sucrose (TCBS) agar which gives rise to large and smooth yellow 
colonies that differ from other non-sucrose fermenting bacteria colonies. 
Despite  having  more  than  200  serogroups  of  V.  cholerae  described  so  far,  only 
serogroup O1 and O139 are routinely screened as these serogroups are the causative 
agents  for  prominent  epidemic  and  pandemic  cholera  cases  worldwide.  The 
identification  of  V.  cholerae  O1  serogroup  can  be  performed  using  polyvalent 
antiserum against O1 antigen while for V. cholerae  O139 serogroup identification 
using  monovalent  antiserum  against  O139  antigen.  Whereas,  non-O1/  non-O139 
strains are categorised for isolates that give non-reactive result with both antisera 
during agglutination test.
There are some biochemical tests done for recognition of V. cholerae bacterium such 
as  Oxidase  test,  String  test  and  Triple  sugar  iron  test.  In  purpose  for  cholera 
intervention,  identification  of  V.  cholera  O1  isolate’s  serotype  and  biotype  is 
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unnecessary,  however,  the  data  collected  is  helpful  in  epidemiological  study.  In 
serotyping  test,  a  monovalent  antiserum  of  Inaba  and  Ogawa  is  used  whereas 
biotyping test can be performed using several tests inclusive of Voges-Proskauer test, 
polymyxin B susceptibility test, hemagglutination test with chicken red blood cells 
and susceptibility to bacteriophages to distinguish either Classical or El Tor biotype 
(Bopp et al., 1999; Feng et al., 2008; Kaper et al., 1995). 
During the early stages of an outbreak where the incidence of cholera is still low, an 
expression  of  CT  is  compulsory  to  perform  in  cholera  endemic  settings  for 
surveillance and as precautions for potential of outbreaks to occur. Production of CT 
enterotoxin can be done using rabbit ileum loop test, cell culture-based tests, GM1-
ELISA  assay  and  reversed  passive  latex  agglutination  test  (RPLA)  that  is 
commercially available.  
Nevertheless, these assay’s processes exceed 12 hours of incubative period and in 
consequence,  the  CT recognition  using rapid  tests  such as  GM1-ELISA or  RPLA 
assay still  needs 2 days to  obtain the results.  In  addition,  these assays are  time-
consuming,  laborious,  and  limited  sensitivity,  particularly  for  improper  sample 
collections  or  patient’s  samples  that  previously  treated  with  antibiotic  or  with 
traditional home-remedies. 
The diagnosis process may also be hindered in conditions of low numbers of viable 
organisms present or exist in a viable but non-culturable state (Senoh et al., 2010). 
Therefore, a molecular amplification-based technique is the best possible detection 
method for detecting the toxigenic genes of V. cholerae strains as the results can be 
acquired within a few hours compared with conventional methods.
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1.2.8. Loop-mediated isothermal amplification (LAMP)
Molecular amplification-based techniques are one of the most precious implements 
in all life science fields like in diagnosis of infectious diseases, genetic disorders and 
even  in  agriculture  and  fisheries.  Rapidity,  ease  of  operation  handling,  highly 
sensitive  and  specific  is  criteria  needed  in  facilitating  a  particular  reliable  and 
efficient  diagnosis  system.  Loop-mediated  isothermal  amplification  (LAMP) 
technique  is  one  of  DNA amplification  methods  which  possesses  these  criteria 
compared  with  other  molecular  amplification-based  techniques  referred  to  PCR, 
nucleic  acid  sequence-based  amplification  (NASBA),  strand  displacement 
amplification  (SDA) and other  molecular  techniques.  It  is  also  be  claimed to  be 
stable compared with PCR and real time PCR when using clinical samples in which 
some  components  that  present  in  the  sample  may  be  hinder  or  inhibit  the  Taq 
polymerase unlike Bst polymerase. 
Since it was first reported by the Japanese research groups in 2000 (Notomi et al. 
2000), LAMP has been extensively applied from conventional LAMP until recently 
reported as real-time LAMP by using DNA probes for multiplex target. The entire 
process is straightforward and rapid where under isothermal conditions, the DNA 
amplification can be finished in less than 60 minutes by using three sets of specific 
primers which recognise eight individual sequences of target gene and it occurs in 
the same single tube.
The principle of LAMP involves the Bst DNA polymerase enzyme performing auto-
cyclic strand displacement activity under isothermal temperatures is explained with 
Figure 1.1. 
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Figure 1.1 Principles  of  LAMP  amplification.  Non-Cyclic  Step  [1—8]: 
Generation of stem loop DNA with dumbbell-shaped structure at both ends that is 
ready to enter into cyclic amplification step. Initially, the strand displacement activity 
of Bst DNA polymerase helps in synthesis of complementary DNA strand, starting 
with FIP. The outer primer (F3) then displaces the FIP-linked complementary strand, 
which forms a stem-loop structure at the 5’ end. This serves as a template for BIP-
initiated  DNA  synthesis  and  subsequent  B3-primed  strand  displacement  DNA 
synthesis.  The  final  product  is  a  structure  with  stem-loops  at  each  end.  Cyclic 
Amplification Step [9—11]: Exponential amplification of original dumbbell-shaped 
stem-loop  DNA employing  internal  primers.  The  product  is  the  differently  sized 
structures  consisting of  alternately inverted repeats  of  the target  sequence on the 
same strand, giving a cauliflower-like structure. Adopted from Eiken Chemical Co. 
Ltd., Japan.
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The LAMP amplification process comprises two main steps which are non-cyclic and 
cyclic steps. A stem-loops DNA was formed at every one of structure  during non-
cyclic process and they function as the beginning structure for LAMP cyclic steps. It 
started with annealing of FIP primer to complementary nucleotide sequences which 
later DNA amplification is initiated by Bst DNA polymerase and releasing a single 
stranded DNA due to its strand displacement activity of this enzyme.
The single stranded DNA produced is beginning from 3’ end of FIP (F2 region). 
Then, the F3c region located outside of FIP is annealed by F3 primer and commence 
the activity of strand replacement, freeing the FIP-linked complementary strand. The 
complementary regions between F1c and F1 on this single stranded DNA leads to 
formation of stem-loop structure at 5’ end which functions as DNA template for BIP-
initiated  DNA  synthesis  and  following  B3-primed  strand  displacement  DNA 
synthesis. A similar process happens to BIP region and lastly when the BIP-linked 
complementary strand displaced; it constructs a stem-loops at every one of structure 
which appears as dumbbell shape. This dumbbell shape functions as DNA template 
for LAMP cyclic amplification process.
In next LAMP series, the FIP primer hybridises to the dumbbell shape loop then 
commence the strand displacement DNA combination, generating the first stem-loop 
DNA and also recently developed stem-loop DNA with size twice long. Briefly the 
FIP recombines to single stranded district in the stem-loop DNA followed by strand 
displacement activity, loose out the formerly synthesised strand. A single strand  was 
released and shaped into stem-loop structure at the 3’ end due to complementary B1c 
and  B1  districts.  At  that  time,  beginning  from  3’ end  of  the  B1  district,  DNA 
construction begins utilising self-structure as DNA template and loose out FIP-linked 
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complementary strand. The loose out single strand then shaped into dumbbell-like 
structure  as  both  ends  have  complementary  F1-F1c  and  B1c-B1  districts, 
respectively.  Moreover,  BIP  recombines  to  B2c  district  followed  by  strand 
displacement  activity,  loosing  out  the  B1-primed  DNA  strand.  Consequently, 
assorted proportions of DNA structure comprises of alternately inverted repeats of 
target sequence on the same strand are constructed. 
The rotation series reaction persist and produce a mass of 109 copies of interested 
gene in less than 60 minutes. Eventually, the end products are stem-loop DNAs with 
assorted  inverted  repeats  of  target  sequence  and  cauliflower-like  shapes  with 
numerous loops shaped by recombining between alternately inverted repeats of the 
target in the same strand.
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1.3. Rationale of study
Despite the fact that great immense of global development in medical field, cholera 
still  remains a major challenge at  global  level  particularly in Sub-Saharan Africa 
known to be cholera hotspot. In previous years back, a chain of cholera pandemic 
disasters  occurred  which  describe  the  pathogenicity  of  the  disease  caused  by  V. 
cholerae O1 serogroup. 
Diagnostic method for cholera mainly focus on isolation and detection of the bacteria 
by culture method and biochemical tests in which are time-consuming and tedious in 
the  case  of  bacterial  culture  (Dick  et  al.,  2012).  In  addition,  skilful  and  trained 
personnel  are  required  to  perform  the  tests.  However,  limited  facilities  exist  at 
developing countries have delaying the diagnosis process. 
As  a  result,  some  studies  have  shown  attempts  to  develop  a  rapid  and  specific 
diagnostic  test  that  allows  V.  cholerae  diagnosis  in  shorter  time  and  assists  the 
intervention  like  Cholera  SMART kit  which  provides  100% specificity  and  96% 
sensitivity in comparison with gold standard tests (Hasan et al., 1994). However, a 
detection kit rarely gives 100% sensitivity in which it is unable to detect the presence 
of low concentration of analyte target in specimens. 
Molecular amplification method like PCR known as highly adaptable and powerful 
molecular tool that is utilised across divergent disciplines. Nonetheless, this tool has 
yet to be intensively utilised particularly in the diagnosis of microbial agents while 
the time-consuming conventional tests still been used for detection of V. cholerae. 
Thus, the consequence barriers which hinder the full implementation of PCR as the 
main  diagnostic  tool  are  requirement  for  expensive  thermocycler  machine,  time-
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consuming (requires at least 2 - 3 hours), skilled expertise to perform the task, and 
detection of PCR amplicons using conventional agarose gel electrophoresis. 
Whereas, LAMP method only requires simple instrument which can provide a stable 
temperature control like heating block or water bath, rapid (requires at least 1 - 2 
hours), simple operating procedure to perform and the amplicons can be detected 
merely by turbidity  level,  or  by adding fluorescence dye or  even by agarose gel 
electrophoresis. The LAMP method also offers high sensitivity until femtogram level 
and high specificity (due to implementation of three sets of primers) in detection of 
target genes and rapid compared with PCR method. It also can be used directly from 
clinical samples without concerning any inhibitors which might present unlike PCR 
(Kaneko et al., 2007). 
The present study aims to develop a LAMP assay for the detection of toxigenic V. 
cholerae. This assay is made easy to perform and also eliminates the need for cold-
chain  transportation  and  storage  via  thermostabilization  technology.  An  internal 
control is also integrated into the proposed assay to ensure the validity of the assay 
results. This study describes for the first time complete in-house development LAMP 
assay kit that features the use of thermostabilized ready-to-use assay reagents. 
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1.4. Objective (s) of research study
The aim of this study is to develop a thermostabilised multiplex LAMP assay for the 
detection of toxigenic V. cholerae.
The objectives of this research project are as follows:
1. To develop multiplex LAMP assay for detection of toxigenic V. cholerae strains
- To construct specific LAMP primers targeting ctxA gene and internal control
- To optimise the monoplex LAMP assay parameters
- To integrate and optimise an internal control for validation of multiplex LAMP 
assay
2. To  develop  a  thermostabilised  multiplex  LAMP assay  utilising  the  designed 
LAMP primers 
- To  optimise  the  enzyme  stabiliser  combinations  on  the  thermostabilised 
multiplex LAMP assay
- To determine the accelerated stability of the thermostabilised multiplex LAMP 
assay
3. To evaluate the developed thermostabilised multiplex LAMP assay
- To  evaluate  the  analytical  sensitivity  of  the  developed  thermostabilised 
multiplex LAMP assay
- To  evaluate  the  analytical  specificity  of  the  developed  thermostabilised 
multiplex LAMP assay on Gram positive bacteria, Gram negative bacteria and 
V. cholerae clinical isolates
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1.5. Experimental overview of study
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. Selection of 
target gene 
. Construction of Bacterial strains 
internal control 
- -
Reference strains 
~ Clinical isolates (archive samples) 
. Design specific LAMP primers 
using bioinformatics software n 
Development of monoplex LAMP assay 
- Optimization of monoplex LAMP 
- Determination of LAMP primers specificity 
+ 
Development of multiplex LAMP assay 
- Optimization of multiplex LAMP parameters 
- Incorporation of internal control 
~ 
Thermostabilization of multiplex LAMP assay 
- Optimization of enzyme stabiliser and Bst DNA polymerase 
Determination of stability of the thermostabilized LAMP 
reagents 
l 
Evaluation 
- Evaluation of sensitivity and specificity of the thermostabilized 
multiplex LAMP assay 
- Accelerated stability evaluation at 4°C, 25°C, 37°C and 56°C 
CHAPTER 2
2. MATERIALS AND METHODS
2.1. Materials
2.1.1. Bacterial strains
A total of 100 V. cholerae strains, 5 Vibrio species and 91 Gram positive and Gram 
negative  bacterial  strains  were  acquired  from  the  archive  of  Cholera  Research 
Laboratory,  Department  of  Medical  Microbiology  and  Parasitology,  School  of 
Medical Sciences, Health Campus, Universiti Sains Malaysia (USM) and also Stock 
Culture Laboratory, Department of Medical Microbiology and Parasitology, USM. 
Apart from total 196 bacterial strains collected, 81 bacterial strains were used for 
preliminary specificity test as mentioned in section 3.2.1 while 115 bacterial strains 
were used in analytical  specificity for thermostabilised multiplex LAMP assay as 
mentioned in section 3.5.3. Reference strain of V. cholerae J 3321, serogroup O1, El 
Tor biotype was obtained from archive of Cholera Research Laboratory and it was 
used  for  standardisation  and  optimization  for  LAMP assay.  The  list  of  bacterial 
strains utilised in present study are recorded in Table 2.1.
2.1.2. DNA Plasmid
The DNA plasmid which has been utilised in this study was available in Cholera 
Research Laboratory, Department of Medical Microbiology and Parasitology, School 
of Medical Sciences, Health Campus, Universiti Sains Malaysia (USM) and stored in 
archive plasmid collections at - 80 ºC until use. The DNA plasmid used is a SSP2 
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